Bringing world class clinical research to Africa...
Empowering the most vulnerable through scientific excellence and ethical curation. We connect global innovation with local expertise.
Specialist Network
Dedicated Oncology and Cardiology sites across the continent.
Elevating African Clinical Research
Innovatrials operates at the intersection of international standards and regional nuance. With core operations in South Africa and Kenya, we bridge the gap in healthcare access.
Our approach is rooted in the belief that African patients deserve a central role in the development of life-saving therapies. We curate research that respects local communities while maintaining rigorous global compliance.
3+
Active Sites
50k+
Patients Impacted Monthly
Our Motivation
Our approach is rooted in the belief that African patients deserve a central role in the development of life-saving therapies. We curate research that respects local communities while maintaining rigorous global compliance.
We are driven by the goal of empowering the most vulnerable members of African communities for a brighter future.
Recruitment Power & Inclusivity
InNovaTrials deploys a multi-channel recruitment engine to ensure diverse enrolment:
- check_circle Community Advisory Boards for cultural trust
- check_circle Hospital & clinic databases for precision targeting
- check_circle Community recruitment officers embedded locally
- check_circle Physician network referrals
- check_circle Social media outreach to urban and younger populations
- check_circle Health awareness campaigns to educate communities
- check_circle Digitised medical records for rapid identification
This guarantees inclusive representation across age, gender, socioeconomic, and geographic lines, directly aligned with FDA’s mandate for diversity in clinical trials.
Proven Experience, Now Applied in Kenya
Sponsors benefit from experienced teams with global credentials, now applied to a strategically positioned site in East Africa.
Leadership Track Record
Hashim Tayob and Yvette Erasmus recruited over 3,000 participants for a large-scale tuberculosis vaccine trial in South Africa — one of the most demanding therapeutic areas globally.
Kenya Site Strength
Built on the same operational discipline, recruitment expertise, and award-winning leadership, with established investigators in Nairobi.
Operational Excellence
Rapid start-up with precision training and submissions.
Dedicated ethics committees for streamlined protocol reviews.
Ownership model ensuring accountability from first patient in to last database lock.
Inspection-ready quality systems: ICH-GCP, Declaration of Helsinki, and local regulatory compliance embedded throughout.
Comprehensive Solutions
End-to-end support for clinical trials, ensuring every protocol is met with scientific precision and ethical integrity.
Patient Recruitment
Our community-centric recruitment model ensures diverse, representative participation while providing full transparency to participants.
Protocol Management
Rigorous adherence to international ICH-GCP guidelines adapted for the local context.
Regulatory Affairs
Navigating complex regional legal frameworks with absolute precision and speed.
Project Management
Streamlined coordination between sponsors, CROs, and clinical sites.
Site Monitoring
Real-time data oversight ensuring the highest quality of research output.
Therapeutic Areas of Focus
Our curated research network is designed to address the most pressing health challenges across the African continent through specialized sites and expert investigators.
Infectious Diseases
Dermatology
Immunology
Oncology
Cardiology
Gynaecology
Neurology
Gastroenterology
Urology
Mental Health
Pulmonology
Rheumatology
Endocrinology
Paediatrics
Device Studies
In-Hospital Studies
Infectious Diseases & Vaccines
location_on Nairobi Hub
Principal Investigator
Dr Paul Otieno Yonga
MBChB, MRCP (UK), MSc
Renowned for academic rigor and sponsor confidence, Dr. Yonga brings deep expertise in HIV, TB, viral hepatitis, STIs, emerging/travel infections, and vaccinology.
Additional Specialist Access
Cardiology
local_hospital Karen Hospital, Nairobi
Principal Investigator
Dr Antony Gikonyo
MBChB, MRCP (UK)
Facility Highlight
102-bed Karen Hospital facility with state-of-the-art MRI, CT, and angiography capabilities for complex cardiac imaging.
Supported Trials
- Cardiovascular Outcomes
- Metabolic & Device Studies
- Advanced Protocols
Oncology
location_on Nairobi
Principal Investigator
Dr Primus Ochieng
MBChB, MMed, FCRO (SA)
A recognized national leader in oncology research, steering multidisciplinary approaches to cancer care.
Supported Trials
Lab Collaboration: Medlynks
science Connect Afya Subsidiary
Our seamless integration with Medlynks provides trials with high-throughput diagnostic support and rigorous quality control.
600+
Diagnostic Tests
State-of-the-art Technology
verified Verified Quality Systems
Our Footprint in Kenya
Nairobi serves as our strategic operational hub, offering a world-class environment for clinical excellence.
Population: ~55M
Median age ~20, providing a wide and diverse demographic.
Regulatory Framework
Aligned internationally with established ethics committees and PPB oversight.
English Documentation
Full English-language documentation and reporting for global compatibility.
Experienced Investigators
Passionate specialists across urban and rural settings.
Strategic Mandate
Single partner, multi-country execution – consistent SOPs, teams and data standards.
Phase 1
Current operations in the Kenyan hub.
Phase 2
Expansion into Uganda & Tanzania.
Phase 3
Strategic entry into Rwanda.
map Location Advantages
Central Position
Daykio Plaza, Nairobi, near Kenyatta National Hospital for tertiary care access.
Transport Access
Connectivity via Ngong Road with abundant public transport options.
Diverse Population
Strategic position between Kibera and Kilimani for diverse socio-economic access.
Hospital Proximity
Close to Nairobi Hospital and Coptic Hospital for referral pathways.
clinical_notes Clinical Setting
Multi-Specialist Core Site
Breadth of expertise including Endocrinology and Pediatrics supporting complex multi-therapeutic trials.
GP Practice with Specialist Oversight
Site is based in a general practice owned and managed by an Infectious Disease specialist.
Hospital Proximity
Rapid referral mechanisms and emergency support through nearby tertiary facilities.
trending_up Value for Global Sponsors
Why Kenya Matters
- • High disease burden (Infectious & NCDs)
- • Young population (median age 20)
- • Strong economic growth (~5% annually)
Strategic Advantage
Inclusive data for FDA/EMA submissions and foundation for future commercial entry in African markets.
The InnovaTrials Advantage
Quality
- GCP
- Audit readiness
- Experienced leadership
Quantity
- 50 000+ Patients/Month
- Referral networks
- Community Advisory Boards
- Naïve populations
Speed
- Fast feasibility
- Fast contracts
- Fast FPI
The InnovaTrials Team
Yvette Erasmus
(RN, OHNP) COO
A seasoned Chief Operating Officer and clinical trial veteran, known for operational excellence, scaling complex research programs, ensuring regulatory compliance, and delivering high-impact outcomes across global clinical development initiatives.
Hashim Tayob
CEO
A dynamic performance strategist and resource manager specializing in optimizing operational efficiency, aligning talent with organizational goals, and driving sustainable growth through data-driven decision-making and strategic resource allocation.
Elly Dickson
Country Operations
Distinguished clinical research leader driving regional growth, forging strategic partnerships, and advancing research excellence across East Africa’s evolving clinical trial landscape.
Dr. Primus Ochieng
Oncologist
Nationally recognised oncology leader and academic programme director.
Dr. Paul Yonga
Infectious Disease Specialist
Internationally trained Consultant Infectiologist & Clinical Epidemiologist.
Dr. A.K. Gikonyo
Cardiologist
Interventional Cardiologist – The Karen Hospital (102-bed multispecialty centre with MRI, CT, angiography & catheterisation labs).
